• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    More On ACTC

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Ocata Therapeutics, Inc. (ACTC)

    -Other OTC
    6.98 Up 0.18(2.65%) Nov 13
    Add to Portfolio
    Prev Close:6.80
    Open:6.84
    Bid:N/A
    Ask:N/A
    1y Target Est:16.00
    Beta:1.42
    Next Earnings Date:N/A
    Day's Range:6.84 - 7.12
    52wk Range:5.00 - 12.73
    Volume:67,658
    Avg Vol (3m):223,072
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACTC

    Comparison

    Symbol% ChgMkt Cap
    ACTCUp 2.65%N/A
    GERNUp 3.62%495.21M
    STEMUp 3.76%60.76M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advanced Cell Technology, Inc., a biotechnology company, develops and commercializes human pluripotent stem cell technology in the field of regenerative medicine in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback